Ingreelle Chewable Tablet 5mg (Montelukast Sodium)

Adult dose

Adults and adolescents aged 15 years and older take 10 mg of montelukast once daily orally. The 10 mg oral disintegrating film is taken by placing it on the tongue once daily and allowing it to dissolve without water. Patients with asthma and allergic rhinitis take one tablet, one pouch, or one sheet in the evening once daily. This medication should be administered one hour before or two hours after meals.

Child dose

Children aged 6 to 14 years take 5 mg of montelukast once daily by chewing. Children aged 6 to 14 years take 5 mg of montelukast once daily by placing it on the tongue and allowing it to dissolve without water. 6 to

This medication contains the artificial sweetener aspartame, which should be used with caution in patients with phenylketonuria, a hereditary disease that is sensitive to phenylalanine. Daily consumption of aspartame should be controlled to be below the recommended amount by WHO, with the maximum dosage determined according to body weight. Patients who are hypersensitive to this medication should not take it. Various adverse reactions such as fatigue, headache, indigestion, cough, rash, etc. may occur during use; if symptoms are severe or persistent, consult a doctor. While safety has been confirmed through clinical trials for children, adolescents, and adult asthma patients, there have also been reports of neuropsychiatric symptoms, so caution is necessary. This medication is not intended for use during acute asthma attacks; a separate fast-acting inhaler should be kept ready for emergencies. When gradually reducing the dosage of inhaled corticosteroids, follow the doctor's instructions, and avoid sudden changes. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid using those medications while taking this drug. Rarely, asthma patients may experience vascular inflammation related to systemic eosinophilia, necessitating observation. This medication has not been reported to have significant interactions with other drugs when used in combination, but caution is needed when co-administered with certain medications. Use during pregnancy should only be when necessary, and use during breastfeeding should also be done cautiously. Safety has been verified in pediatric and elderly patients, but care should be taken based on age. There is no specific antidote for overdose; general symptomatic treatment and clinical monitoring are required. Sensitive to light, so it should not be opened until just before use, and should be taken immediately after preparation. Keep out of reach of children and do not transfer to other containers. This medication should be taken continuously even when asthma symptoms are absent, and if symptoms worsen, consult a doctor immediately. Patients with exercise-induced asthma should avoid using this medication alone and should continue to use inhaled bronchodilators if needed. If any neuropsychiatric symptoms occur during use, notify a doctor. Patients with aspirin hypersensitivity should avoid taking aspirin and non-steroidal anti-inflammatory drugs. Patients with phenylketonuria must be informed about the presence of aspartame.

Serious side effects

• Hives
• severe swelling (edema)
• angioedema
• chest tightness
• difficulty breathing
• anaphylaxis
• thrombocytopenia
• toxic epidermal necrolysis
• Stevens-Johnson syndrome
• severe rash with high fever

Mild side effects

• Weakness/Fatigue
• fever
• abdominal pain
• indigestion
• infectious gastroenteritis
• toothache
• dizziness
• headache
• nasal congestion
• cough

This medication is sensitive to air, moisture, and light; therefore, it must be stored in a tightly sealed container. It is best to maintain room temperature between 1 degree and 30 degrees. Proper storage will help maintain the medication's effectiveness.

Appearance

Pink chewable tablet that is biconvex in shape

Package unit

30 tablets (10 tablets/PTP x 3), 28 tablets (7 tablets/PTP x 4)